相关实验视频
Updated: Jul 11, 2025

12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
18.6K
DMFDDI:用于药物相互作用预测的深度多式联络融合
Yanglan Gan1, Wenxiao Liu1, Guangwei Xu1
1School of Computer Science and Technology, Donghua University, 2999 North Renmin Road, 201600, Shanghai, China.
Briefings in bioinformatics
|November 6, 2023
概括
预测药物相互作用 (DDI) 对患者安全至关重要. 一个新的深度多式联络功能融合框架,DMFDDI,集成分子图形,DDI网络和生物化学相似性,以提高DDI预测的准确性.
科学领域:
- 药理学和计算机生物学
- 药物发现和开发 药物发现和开发
背景情况:
- 药物组合治疗对于复杂疾病越来越重要.
- 药物相互作用 (DDI) 存在风险,需要准确的预测.
- 现有的用于DDI预测的深度学习方法因功能范围而受到限制.
研究的目的:
- 开发一种新的深度多式联运特征融合框架 (DMFDDI),用于增强DDI预测.
- 整合多样化的药物特征,包括分子图,DDI网络和生物化学相似性.
- 提高DDI预测模型的准确性和稳定性.
主要方法:
- 利用注意力关闭图形神经网络提取全面的药物分子图形特征.
- 使用稀疏的图形卷积网络来学习DDI网络的拓结构.
- 实施了一种多式联动功能融合模块,具有集成各种药物特征的注意力机制.
主要成果:
- 与10种最先进的DDI预测方法相比,DMFDDI表现优越.
- 多式联络融合方法有效地提高了DDI预测的准确性.
- 该框架成功地整合了分子,网络和生物化学药物特征.
结论:
- 拟议的DMFDDI框架在DDI预测方面取得了重大进展.
- 通过多式联机融合整合多种特征类型是提高预测性能的关键.
- 在临床应用中,DMFDDI为提高药物安全提供了有价值的工具.
相关概念视频
Combined Effects of Drugs: Synergism
4.0K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.0K
Combined Effects of Drugs: Antagonism
8.5K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.5K
Drug-Receptor Interactions
5.3K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.3K
Drug-Receptor Interaction: Antagonist
3.0K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
3.0K
Drug-Receptor Interaction: Agonist
2.5K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.5K
Quantitative Aspects of Drug-Receptor Interaction
1.0K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.0K

